{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:49:05Z","timestamp":1774946945957,"version":"3.50.1"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11746-6","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:45:49Z","timestamp":1774943149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of MicroRNAs in Alzheimer\u2019s disease: from pathogenesis to therapeutic potential"],"prefix":"10.1007","volume":"53","author":[{"given":"Yingxue","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwu","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"10284","key":"11746_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE et al (2021) Alzheimer\u2019s disease. Lancet 397(10284):1577\u20131590. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4","journal-title":"Lancet"},{"issue":"20","key":"11746_CR2","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","volume":"186","author":"M Jucker","year":"2023","unstructured":"Jucker M, Walker LC (2023) Alzheimer\u2019s disease: From immunotherapy to immunoprevention. Cell 186(20):4260\u20134270. https:\/\/doi.org\/10.1016\/j.cell.2023.08.021","journal-title":"Cell"},{"key":"11746_CR3","doi-asserted-by":"publisher","first-page":"102309","DOI":"10.1016\/j.arr.2024.102309","volume":"97","author":"K Rajendran","year":"2024","unstructured":"Rajendran K, Krishnan UM (2024) Mechanistic insights and emerging therapeutic stratagems for Alzheimer\u2019s disease. Ageing Res Rev 97:102309. https:\/\/doi.org\/10.1016\/j.arr.2024.102309","journal-title":"Ageing Res Rev"},{"issue":"4","key":"11746_CR4","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"TX Lu","year":"2018","unstructured":"Lu TX, Rothenberg ME (2018) MicroRNA. J Allergy Clin Immunol 141(4):1202\u20131207. https:\/\/doi.org\/10.1016\/j.jaci.2017.08.034","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"11746_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nrg3162","volume":"13","author":"AE Pasquinelli","year":"2012","unstructured":"Pasquinelli AE (2012) MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 13(4):271\u2013282. https:\/\/doi.org\/10.1038\/nrg3162","journal-title":"Nat Rev Genet"},{"issue":"1","key":"11746_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41398-024-03075-8","volume":"14","author":"YB Li","year":"2024","unstructured":"Li YB, Fu Q, Guo M, Du Y, Chen Y, Cheng Y (2024) MicroRNAs: pioneering regulators in Alzheimer\u2019s disease pathogenesis, diagnosis, and therapy. Transl Psychiatry 14(1):367. https:\/\/doi.org\/10.1038\/s41398-024-03075-8","journal-title":"Transl Psychiatry"},{"issue":"1","key":"11746_CR7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W (2023) Amyloid beta-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther 8(1):248. https:\/\/doi.org\/10.1038\/s41392-023-01484-7","journal-title":"Signal Transduct Target Ther"},{"key":"11746_CR8","doi-asserted-by":"publisher","first-page":"102090","DOI":"10.1016\/j.arr.2023.102090","volume":"92","author":"D Rezaee","year":"2023","unstructured":"Rezaee D, Saadatpour F, Akbari N, Zoghi A, Najafi S, Beyranvand P et al (2023) The role of microRNAs in the pathophysiology of human central nervous system: A focus on neurodegenerative diseases. Ageing Res Rev 92:102090. https:\/\/doi.org\/10.1016\/j.arr.2023.102090","journal-title":"Ageing Res Rev"},{"issue":"2","key":"11746_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.expneurol.2011.11.013","volume":"235","author":"N Schonrock","year":"2012","unstructured":"Schonrock N, Matamales M, Ittner LM, Gotz J (2012) MicroRNA networks surrounding APP and amyloid-beta metabolism\u2013implications for Alzheimer\u2019s disease. Exp Neurol 235(2):447\u2013454. https:\/\/doi.org\/10.1016\/j.expneurol.2011.11.013","journal-title":"Exp Neurol"},{"key":"11746_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.brainres.2011.10.051","volume":"1455","author":"C Liang","year":"2012","unstructured":"Liang C, Zhu H, Xu Y, Huang L, Ma C, Deng W et al (2012) MicroRNA-153 negatively regulates the expression of amyloid precursor protein and amyloid precursor-like protein 2. Brain Res 1455:103\u2013113. https:\/\/doi.org\/10.1016\/j.brainres.2011.10.051","journal-title":"Brain Res"},{"issue":"3","key":"11746_CR11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.neurobiolaging.2010.04.034","volume":"33","author":"W Liu","year":"2012","unstructured":"Liu W, Liu C, Zhu J, Shu P, Yin B, Gong Y et al (2012) MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer\u2019s-associated pathogenesis in SAMP8 mice. Neurobiol Aging 33(3):522\u2013534. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.04.034","journal-title":"Neurobiol Aging"},{"issue":"9","key":"11746_CR12","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.bbadis.2019.06.006","volume":"1865","author":"S Kumar","year":"2019","unstructured":"Kumar S, Reddy AP, Yin X, Reddy PH (2019) Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer\u2019s disease. Biochim Biophys Acta Mol Basis Dis 1865(9):2428\u20132440. https:\/\/doi.org\/10.1016\/j.bbadis.2019.06.006","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"3","key":"11746_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41380-018-0266-3","volume":"24","author":"JM Long","year":"2019","unstructured":"Long JM, Maloney B, Rogers JT, Lahiri DK (2019) Novel upregulation of amyloid-beta precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5\u2019-untranslated region: Implications in Alzheimer\u2019s disease. Mol Psychiatry 24(3):345\u2013363. https:\/\/doi.org\/10.1038\/s41380-018-0266-3","journal-title":"Mol Psychiatry"},{"issue":"10","key":"11746_CR14","doi-asserted-by":"publisher","first-page":"5636","DOI":"10.1038\/s41380-019-0610-2","volume":"26","author":"N Chopra","year":"2021","unstructured":"Chopra N, Wang R, Maloney B, Nho K, Beck JS, Pourshafie N et al (2021) MicroRNA-298 reduces levels of human amyloid-beta precursor protein (APP), beta-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties. Mol Psychiatry 26(10):5636\u20135657. https:\/\/doi.org\/10.1038\/s41380-019-0610-2","journal-title":"Mol Psychiatry"},{"issue":"3","key":"11746_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/WNR.0000000000001379","volume":"31","author":"N Zhang","year":"2020","unstructured":"Zhang N, Li WW, Lv CM, Gao YW, Liu XL, Zhao L (2020) miR-16-5p and miR-19b-3p prevent amyloid beta-induced injury by targeting BACE1 in SH-SY5Y cells. NeuroReport 31(3):205\u2013212. https:\/\/doi.org\/10.1097\/WNR.0000000000001379","journal-title":"NeuroReport"},{"key":"11746_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.brainres.2014.04.026","volume":"1583","author":"CG Liu","year":"2014","unstructured":"Liu CG, Wang JL, Li L, Xue LX, Zhang YQ, Wang PC (2014) MicroRNA-135a and \u2013\u2009200b, potential Biomarkers for Alzheimer\u05f3s disease, regulate beta secretase and amyloid precursor protein. Brain Res 1583:55\u201364. https:\/\/doi.org\/10.1016\/j.brainres.2014.04.026","journal-title":"Brain Res"},{"issue":"2","key":"11746_CR17","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3892\/etm.2016.3366","volume":"12","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Xing H, Guo S, Zheng Z, Wang H, Xu D (2016) MicroRNA-135b has a neuroprotective role via targeting of beta-site APP-cleaving enzyme 1. Exp Ther Med 12(2):809\u2013814. https:\/\/doi.org\/10.3892\/etm.2016.3366","journal-title":"Exp Ther Med"},{"key":"11746_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fnmol.2014.00067","volume":"7","author":"C Delay","year":"2014","unstructured":"Delay C, Dorval V, Fok A, Grenier-Boley B, Lambert JC, Hsiung GY et al (2014) MicroRNAs targeting Nicastrin regulate Abeta production and are affected by target site polymorphisms. Front Mol Neurosci 7:67. https:\/\/doi.org\/10.3389\/fnmol.2014.00067","journal-title":"Front Mol Neurosci"},{"issue":"4","key":"11746_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s12031-016-0815-7","volume":"60","author":"Q Li","year":"2016","unstructured":"Li Q, Li X, Wang L, Zhang Y, Chen L (2016) miR-98-5p Acts as a Target for Alzheimer\u2019s Disease by Regulating Abeta Production Through Modulating SNX6 Expression. J Mol Neurosci 60(4):413\u2013420. https:\/\/doi.org\/10.1007\/s12031-016-0815-7","journal-title":"J Mol Neurosci"},{"issue":"8","key":"11746_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E et al (2015) Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol 11(8):457\u2013470. https:\/\/doi.org\/10.1038\/nrneurol.2015.119","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"11746_CR21","doi-asserted-by":"publisher","first-page":"e0150211","DOI":"10.1371\/journal.pone.0150211","volume":"11","author":"S Bhattacharjee","year":"2016","unstructured":"Bhattacharjee S, Zhao Y, Dua P, Rogaev EI, Lukiw WJ (2016) microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular Degeneration. PLoS ONE 11(3):e0150211. https:\/\/doi.org\/10.1371\/journal.pone.0150211","journal-title":"PLoS ONE"},{"issue":"1","key":"11746_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","volume":"20","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo A, Das S, Hyman BT (2021) APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol 20(1):68\u201380. https:\/\/doi.org\/10.1016\/S1474-4422(20)30412-9","journal-title":"Lancet Neurol"},{"issue":"5","key":"11746_CR23","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.cell.2012.10.028","volume":"151","author":"N Pencheva","year":"2012","unstructured":"Pencheva N, Tran H, Buss C, Huh D, Drobnjak M, Busam K et al (2012) Convergent multi-miRNA targeting of ApoE drives LRP1\/LRP8-dependent melanoma metastasis and angiogenesis. Cell 151(5):1068\u20131082. https:\/\/doi.org\/10.1016\/j.cell.2012.10.028","journal-title":"Cell"},{"key":"11746_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.dadm.2015.11.004","volume":"3","author":"JR Guedes","year":"2016","unstructured":"Guedes JR, Santana I, Cunha C, Duro D, Almeida MR, Cardoso AM et al (2016) MicroRNA deregulation and chemotaxis and phagocytosis impairment in Alzheimer\u2019s disease. Alzheimers Dement (Amst) 3:7\u201317. https:\/\/doi.org\/10.1016\/j.dadm.2015.11.004","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"11746_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40035-022-00279-0","volume":"11","author":"L Gao","year":"2022","unstructured":"Gao L, Zhang Y, Sterling K, Song W (2022) Brain-derived neurotrophic factor in Alzheimer\u2019s disease and its pharmaceutical potential. Transl Neurodegener 11(1):4. https:\/\/doi.org\/10.1186\/s40035-022-00279-0","journal-title":"Transl Neurodegener"},{"issue":"1","key":"11746_CR26","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1038\/s41467-021-22196-y","volume":"12","author":"K Zheng","year":"2021","unstructured":"Zheng K, Hu F, Zhou Y, Zhang J, Zheng J, Lai C et al (2021) miR-135a-5p mediates memory and synaptic impairments via the Rock2\/Adducin1 signaling pathway in a mouse model of Alzheimer\u2019s disease. Nat Commun 12(1):1903. https:\/\/doi.org\/10.1038\/s41467-021-22196-y","journal-title":"Nat Commun"},{"key":"11746_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ebiom.2018.11.059","volume":"39","author":"Y Song","year":"2019","unstructured":"Song Y, Hu M, Zhang J, Teng ZQ, Chen C (2019) A novel mechanism of synaptic and cognitive impairments mediated via microRNA-30b in Alzheimer\u2019s disease. EBioMedicine 39:409\u2013421. https:\/\/doi.org\/10.1016\/j.ebiom.2018.11.059","journal-title":"EBioMedicine"},{"key":"11746_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.nbd.2014.08.028","volume":"73","author":"M Cisse","year":"2015","unstructured":"Cisse M, Checler F (2015) Eph receptors: new players in Alzheimer\u2019s disease pathogenesis. Neurobiol Dis 73:137\u2013149. https:\/\/doi.org\/10.1016\/j.nbd.2014.08.028","journal-title":"Neurobiol Dis"},{"issue":"3","key":"11746_CR29","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3892\/ijmm.2017.3339","volume":"41","author":"B Shu","year":"2018","unstructured":"Shu B, Zhang X, Du G, Fu Q, Huang L (2018) MicroRNA-107 prevents amyloid-beta-induced neurotoxicity and memory impairment in mice. Int J Mol Med 41(3):1665\u20131672. https:\/\/doi.org\/10.3892\/ijmm.2017.3339","journal-title":"Int J Mol Med"},{"issue":"1","key":"11746_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1570159X18666200503024700","volume":"19","author":"J Lu","year":"2021","unstructured":"Lu J, Luo Y, Mei S, Fang Y, Zhang J, Chen S (2021) The effect of melatonin modulation of non-coding RNAs on central nervous system disorders: An Updated Review. Curr Neuropharmacol 19(1):3\u201323. https:\/\/doi.org\/10.2174\/1570159X18666200503024700","journal-title":"Curr Neuropharmacol"},{"issue":"8","key":"11746_CR31","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","volume":"21","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele R, van der Kant R, Hansson O (2022) Tau biomarkers in Alzheimer\u2019s disease: towards implementation in clinical practice and trials. Lancet Neurol 21(8):726\u2013734. https:\/\/doi.org\/10.1016\/S1474-4422(22)00168-5","journal-title":"Lancet Neurol"},{"issue":"9","key":"11746_CR32","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.7150\/ijbs.57078","volume":"17","author":"H Zhang","year":"2021","unstructured":"Zhang H, Wei W, Zhao M, Ma L, Jiang X, Pei H et al (2021) Interaction between Abeta and Tau in the Pathogenesis of Alzheimer\u2019s Disease. Int J Biol Sci 17(9):2181\u20132192. https:\/\/doi.org\/10.7150\/ijbs.57078","journal-title":"Int J Biol Sci"},{"key":"11746_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.omtn.2022.04.008","volume":"28","author":"H Jiang","year":"2022","unstructured":"Jiang H, Liu J, Guo S, Zeng L, Cai Z, Zhang J et al (2022) miR-23b-3p rescues cognition in Alzheimer\u2019s disease by reducing tau phosphorylation and apoptosis via GSK-3beta signaling pathways. Mol Ther Nucleic Acids 28:539\u2013557. https:\/\/doi.org\/10.1016\/j.omtn.2022.04.008","journal-title":"Mol Ther Nucleic Acids"},{"issue":"23","key":"11746_CR34","doi-asserted-by":"publisher","first-page":"6721","DOI":"10.1093\/hmg\/ddv377","volume":"24","author":"PY Smith","year":"2015","unstructured":"Smith PY, Hernandez-Rapp J, Jolivette F, Lecours C, Bisht K, Goupil C et al (2015) miR-132\/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo. Hum Mol Genet 24(23):6721\u20136735. https:\/\/doi.org\/10.1093\/hmg\/ddv377","journal-title":"Hum Mol Genet"},{"issue":"2","key":"11746_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1172\/JCI78421","volume":"125","author":"I Santa-Maria","year":"2015","unstructured":"Santa-Maria I, Alaniz ME, Renwick N, Cela C, Fulga TA, Van Vactor D et al (2015) Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau. J Clin Invest 125(2):681\u2013686. https:\/\/doi.org\/10.1172\/JCI78421","journal-title":"J Clin Invest"},{"issue":"1","key":"11746_CR36","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/jcp.28988","volume":"235","author":"B He","year":"2020","unstructured":"He B, Chen W, Zeng J, Tong W, Zheng P (2020) MicroRNA-326 decreases tau phosphorylation and neuron apoptosis through inhibition of the JNK signaling pathway by targeting VAV1 in Alzheimer\u2019s disease. J Cell Physiol 235(1):480\u2013493. https:\/\/doi.org\/10.1002\/jcp.28988","journal-title":"J Cell Physiol"},{"issue":"7","key":"11746_CR37","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT et al (2018) The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain 141(7):1917\u20131933. https:\/\/doi.org\/10.1093\/brain\/awy132","journal-title":"Brain"},{"issue":"11","key":"11746_CR38","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.neurobiolaging.2005.09.034","volume":"27","author":"KF Bell","year":"2006","unstructured":"Bell KF, Ducatenzeiler A, Ribeiro-da-Silva A, Duff K, Bennett DA, Cuello AC (2006) The amyloid pathology progresses in a neurotransmitter-specific manner. Neurobiol Aging 27(11):1644\u20131657. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.09.034","journal-title":"Neurobiol Aging"},{"key":"11746_CR39","doi-asserted-by":"publisher","first-page":"667412","DOI":"10.3389\/fcell.2021.667412","volume":"9","author":"LT Zhou","year":"2021","unstructured":"Zhou LT, Zhang J, Tan L, Huang HZ, Zhou Y, Liu ZQ et al (2021) Elevated Levels of miR-144-3p Induce Cholinergic Degeneration by Impairing the Maturation of NGF in Alzheimer\u2019s Disease. Front Cell Dev Biol 9:667412. https:\/\/doi.org\/10.3389\/fcell.2021.667412","journal-title":"Front Cell Dev Biol"},{"issue":"Pt 3","key":"11746_CR40","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/brain\/awv383","volume":"139","author":"QB Zhu","year":"2016","unstructured":"Zhu QB, Unmehopa U, Bossers K, Hu YT, Verwer R, Balesar R et al (2016) MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer\u2019s disease. Brain 139(Pt 3):908\u2013921. https:\/\/doi.org\/10.1093\/brain\/awv383","journal-title":"Brain"},{"issue":"1\u20132","key":"11746_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s0006-8993(02)03262-6","volume":"953","author":"J Apelt","year":"2002","unstructured":"Apelt J, Kumar A, Schliebs R (2002) Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein. Brain Res 953(1\u20132):17\u201330. https:\/\/doi.org\/10.1016\/s0006-8993(02)03262-6","journal-title":"Brain Res"},{"issue":"6","key":"11746_CR42","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.immuni.2009.09.019","volume":"31","author":"I Shaked","year":"2009","unstructured":"Shaked I, Meerson A, Wolf Y, Avni R, Greenberg D, Gilboa-Geffen A et al (2009) MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity 31(6):965\u2013973. https:\/\/doi.org\/10.1016\/j.immuni.2009.09.019","journal-title":"Immunity"},{"issue":"8","key":"11746_CR43","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1073\/pnas.83.8.2714","volume":"83","author":"DL Shelton","year":"1986","unstructured":"Shelton DL, Reichardt LF (1986) Studies on the expression of the beta nerve growth factor (NGF) gene in the central nervous system: level and regional distribution of NGF mRNA suggest that NGF functions as a trophic factor for several distinct populations of neurons. Proc Natl Acad Sci U S A 83(8):2714\u20132718. https:\/\/doi.org\/10.1073\/pnas.83.8.2714","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11746_CR44","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fnmol.2016.00140","volume":"9","author":"Q Wu","year":"2016","unstructured":"Wu Q, Ye X, Xiong Y, Zhu H, Miao J, Zhang W et al (2016) The Protective Role of microRNA-200c in Alzheimer\u2019s Disease Pathologies Is Induced by Beta Amyloid-Triggered Endoplasmic Reticulum Stress. Front Mol Neurosci 9:140. https:\/\/doi.org\/10.3389\/fnmol.2016.00140","journal-title":"Front Mol Neurosci"},{"key":"11746_CR45","doi-asserted-by":"publisher","first-page":"587747","DOI":"10.3389\/fncel.2020.587747","volume":"14","author":"J Zhuang","year":"2020","unstructured":"Zhuang J, Chen Z, Cai P, Wang R, Yang Q, Li L et al (2020) Targeting MicroRNA-125b Promotes Neurite Outgrowth but Represses Cell Apoptosis and Inflammation via Blocking PTGS2 and CDK5 in a FOXQ1-Dependent Way in Alzheimer Disease. Front Cell Neurosci 14:587747. https:\/\/doi.org\/10.3389\/fncel.2020.587747","journal-title":"Front Cell Neurosci"},{"issue":"15","key":"11746_CR46","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1038\/sj.emboj.7601790","volume":"26","author":"C le Sage","year":"2007","unstructured":"le Sage C, Nagel R, Egan DA, Schrier M, Mesman E, Mangiola A et al (2007) Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26(15):3699\u20133708. https:\/\/doi.org\/10.1038\/sj.emboj.7601790","journal-title":"EMBO J"},{"issue":"1","key":"11746_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-024-00740-w","volume":"19","author":"S Kim","year":"2024","unstructured":"Kim S, Chun H, Kim Y, Kim Y, Park U, Chu J et al (2024) Astrocytic autophagy plasticity modulates Abeta clearance and cognitive function in Alzheimer\u2019s disease. Mol Neurodegener 19(1):55. https:\/\/doi.org\/10.1186\/s13024-024-00740-w","journal-title":"Mol Neurodegener"},{"issue":"12","key":"11746_CR48","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1080\/15548627.2016.1239003","volume":"12","author":"M Bordi","year":"2016","unstructured":"Bordi M, Berg MJ, Mohan PS, Peterhoff CM, Alldred MJ, Che S et al (2016) Autophagy flux in CA1 neurons of Alzheimer hippocampus: Increased induction overburdens failing lysosomes to propel neuritic dystrophy. Autophagy 12(12):2467\u20132483. https:\/\/doi.org\/10.1080\/15548627.2016.1239003","journal-title":"Autophagy"},{"key":"11746_CR49","doi-asserted-by":"publisher","first-page":"705581","DOI":"10.3389\/fimmu.2021.705581","volume":"12","author":"S Estfanous","year":"2021","unstructured":"Estfanous S, Daily KP, Eltobgy M, Deems NP, Anne MNK, Krause K et al (2021) Elevated Expression of MiR-17 in Microglia of Alzheimer\u2019s Disease Patients Abrogates Autophagy-Mediated Amyloid-beta Degradation. Front Immunol 12:705581. https:\/\/doi.org\/10.3389\/fimmu.2021.705581","journal-title":"Front Immunol"},{"issue":"4","key":"11746_CR50","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.3892\/etm.2017.4977","volume":"14","author":"H Gu","year":"2017","unstructured":"Gu H, Li L, Cui C, Zhao Z, Song G (2017) Overexpression of let-7a increases neurotoxicity in a PC12 cell model of Alzheimer\u2019s disease via regulating autophagy. Exp Ther Med 14(4):3688\u20133698. https:\/\/doi.org\/10.3892\/etm.2017.4977","journal-title":"Exp Ther Med"},{"issue":"8","key":"11746_CR51","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1177\/0963689719857085","volume":"28","author":"Q Li","year":"2019","unstructured":"Li Q, Wang Y, Peng W, Jia Y, Tang J, Li W et al (2019) MicroRNA-101a Regulates Autophagy Phenomenon via the MAPK Pathway to Modulate Alzheimer\u2019s-Associated Pathogenesis. Cell Transpl 28(8):1076\u20131084. https:\/\/doi.org\/10.1177\/0963689719857085","journal-title":"Cell Transpl"},{"issue":"5","key":"11746_CR52","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.7150\/thno.47408","volume":"11","author":"ML Chen","year":"2021","unstructured":"Chen ML, Hong CG, Yue T, Li HM, Duan R, Hu WB et al (2021) Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer\u2019s disease by enhancing autophagy. Theranostics 11(5):2395\u20132409. https:\/\/doi.org\/10.7150\/thno.47408","journal-title":"Theranostics"},{"issue":"1","key":"11746_CR53","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1038\/s41467-021-23597-9","volume":"12","author":"M Subramanian","year":"2021","unstructured":"Subramanian M, Hyeon SJ, Das T, Suh YS, Kim YK, Lee JS et al (2021) UBE4B, a microRNA-9 target gene, promotes autophagy-mediated Tau degradation. Nat Commun 12(1):3291. https:\/\/doi.org\/10.1038\/s41467-021-23597-9","journal-title":"Nat Commun"},{"key":"11746_CR54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3389\/fnmol.2020.00090","volume":"13","author":"W Fan","year":"2020","unstructured":"Fan W, Liang C, Ou M, Zou T, Sun F, Zhou H et al (2020) MicroRNA-146a Is a Wide-Reaching Neuroinflammatory Regulator and Potential Treatment Target in Neurological Diseases. Front Mol Neurosci 13:90. https:\/\/doi.org\/10.3389\/fnmol.2020.00090","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"11746_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00401-024-02790-2","volume":"148","author":"P Botella Lucena","year":"2024","unstructured":"Botella Lucena P, Heneka MT (2024) Inflammatory aspects of Alzheimer\u2019s disease. Acta Neuropathol 148(1):31. https:\/\/doi.org\/10.1007\/s00401-024-02790-2","journal-title":"Acta Neuropathol"},{"key":"11746_CR56","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fnint.2013.00059","volume":"7","author":"MA Meraz-Rios","year":"2013","unstructured":"Meraz-Rios MA, Toral-Rios D, Franco-Bocanegra D, Villeda-Hernandez J, Campos-Pena V (2013) Inflammatory process in Alzheimer\u2019s Disease. Front Integr Neurosci 7:59. https:\/\/doi.org\/10.3389\/fnint.2013.00059","journal-title":"Front Integr Neurosci"},{"issue":"10","key":"11746_CR57","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41419-021-04165-x","volume":"12","author":"C Burgaletto","year":"2021","unstructured":"Burgaletto C, Platania CBM, Di Benedetto G, Munafo A, Giurdanella G, Federico C et al (2021) Targeting the miRNA-155\/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer\u2019s disease. Cell Death Dis 12(10):905. https:\/\/doi.org\/10.1038\/s41419-021-04165-x","journal-title":"Cell Death Dis"},{"key":"11746_CR58","doi-asserted-by":"publisher","first-page":"833066","DOI":"10.3389\/fphar.2022.833066","volume":"13","author":"G Garcia","year":"2022","unstructured":"Garcia G, Fernandes A, Stein F, Brites D (2022) Protective Signature of IFNgamma-Stimulated Microglia Relies on miR-124-3p Regulation From the Secretome Released by Mutant APP Swedish Neuronal Cells. Front Pharmacol 13:833066. https:\/\/doi.org\/10.3389\/fphar.2022.833066","journal-title":"Front Pharmacol"},{"key":"11746_CR59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.mcn.2015.07.004","volume":"68","author":"KJ Cho","year":"2015","unstructured":"Cho KJ, Song J, Oh Y, Lee JE (2015) MicroRNA-Let-7a regulates the function of microglia in inflammation. Mol Cell Neurosci 68:167\u2013176. https:\/\/doi.org\/10.1016\/j.mcn.2015.07.004","journal-title":"Mol Cell Neurosci"},{"issue":"18","key":"11746_CR60","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.21037\/atm-21-3903","volume":"9","author":"J Hou","year":"2021","unstructured":"Hou J, Deng Q, Deng X, Zhong W, Liu S, Zhong Z (2021) MicroRNA-146a-5p alleviates lipopolysaccharide-induced NLRP3 inflammasome injury and pro-inflammatory cytokine production via the regulation of TRAF6 and IRAK1 in human umbilical vein endothelial cells (HUVECs). Ann Transl Med 9(18):1433. https:\/\/doi.org\/10.21037\/atm-21-3903","journal-title":"Ann Transl Med"},{"issue":"6","key":"11746_CR61","doi-asserted-by":"publisher","first-page":"e01627","DOI":"10.1002\/brb3.1627","volume":"10","author":"C Han","year":"2020","unstructured":"Han C, Guo L, Yang Y, Guan Q, Shen H, Sheng Y et al (2020) Mechanism of microRNA-22 in regulating neuroinflammation in Alzheimer\u2019s disease. Brain Behav 10(6):e01627. https:\/\/doi.org\/10.1002\/brb3.1627","journal-title":"Brain Behav"},{"issue":"2","key":"11746_CR62","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3892\/mmr.2016.5369","volume":"14","author":"H Xing","year":"2016","unstructured":"Xing H, Guo S, Zhang Y, Zheng Z, Wang H (2016) Upregulation of microRNA-206 enhances lipopolysaccharide-induced inflammation and release of amyloid-beta by targeting insulin-like growth factor 1 in microglia. Mol Med Rep 14(2):1357\u20131364. https:\/\/doi.org\/10.3892\/mmr.2016.5369","journal-title":"Mol Med Rep"},{"issue":"5","key":"11746_CR63","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00401-016-1570-0","volume":"131","author":"A Montagne","year":"2016","unstructured":"Montagne A, Nation DA, Pa J, Sweeney MD, Toga AW, Zlokovic BV (2016) Brain imaging of neurovascular dysfunction in Alzheimer\u2019s disease. Acta Neuropathol 131(5):687\u2013707. https:\/\/doi.org\/10.1007\/s00401-016-1570-0","journal-title":"Acta Neuropathol"},{"key":"11746_CR64","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","volume":"107","author":"E Zenaro","year":"2017","unstructured":"Zenaro E, Piacentino G, Constantin G (2017) The blood-brain barrier in Alzheimer\u2019s disease. Neurobiol Dis 107:41\u201356. https:\/\/doi.org\/10.1016\/j.nbd.2016.07.007","journal-title":"Neurobiol Dis"},{"issue":"2","key":"11746_CR65","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.yexcr.2016.03.026","volume":"343","author":"W Liu","year":"2016","unstructured":"Liu W, Cai H, Lin M, Zhu L, Gao L, Zhong R et al (2016) MicroRNA-107 prevents amyloid-beta induced blood-brain barrier disruption and endothelial cell dysfunction by targeting Endophilin-1. Exp Cell Res 343(2):248\u2013257. https:\/\/doi.org\/10.1016\/j.yexcr.2016.03.026","journal-title":"Exp Cell Res"},{"issue":"2","key":"11746_CR66","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/0271678X15606147","volume":"36","author":"M Bukeirat","year":"2016","unstructured":"Bukeirat M, Sarkar SN, Hu H, Quintana DD, Simpkins JW, Ren X (2016) MiR-34a regulates blood-brain barrier permeability and mitochondrial function by targeting cytochrome c. J Cereb Blood Flow Metab 36(2):387\u2013392. https:\/\/doi.org\/10.1177\/0271678X15606147","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"11746_CR67","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1038\/jcbfm.2015.154","volume":"35","author":"S Rom","year":"2015","unstructured":"Rom S, Dykstra H, Zuluaga-Ramirez V, Reichenbach NL, Persidsky Y (2015) miR-98 and let-7\u00a0g* protect the blood-brain barrier under neuroinflammatory conditions. J Cereb Blood Flow Metab 35(12):1957\u20131965. https:\/\/doi.org\/10.1038\/jcbfm.2015.154","journal-title":"J Cereb Blood Flow Metab"},{"issue":"23","key":"11746_CR68","doi-asserted-by":"publisher","first-page":"6286","DOI":"10.1093\/hmg\/ddu348","volume":"23","author":"JR Guedes","year":"2014","unstructured":"Guedes JR, Custodia CM, Silva RJ, de Almeida LP, Pedroso de Lima MC, Cardoso AL (2014) Early miR-155 upregulation contributes to neuroinflammation in Alzheimer\u2019s disease triple transgenic mouse model. Hum Mol Genet 23(23):6286\u20136301. https:\/\/doi.org\/10.1093\/hmg\/ddu348","journal-title":"Hum Mol Genet"},{"issue":"8","key":"11746_CR69","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","volume":"1842","author":"X Wang","year":"2014","unstructured":"Wang X, Wang W, Li L, Perry G, Lee HG, Zhu X (2014) Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease. Biochim Biophys Acta 1842(8):1240\u20131247. https:\/\/doi.org\/10.1016\/j.bbadis.2013.10.015","journal-title":"Biochim Biophys Acta"},{"key":"11746_CR70","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.omtn.2020.12.014","volume":"23","author":"HN Woo","year":"2021","unstructured":"Woo HN, Park S, Kim HL, Jung MK, Pack CG, Park J et al (2021) miR-351-5p\/Miro2 axis contributes to hippocampal neural progenitor cell death via unbalanced mitochondrial fission. Mol Ther Nucleic Acids 23:643\u2013656. https:\/\/doi.org\/10.1016\/j.omtn.2020.12.014","journal-title":"Mol Ther Nucleic Acids"},{"key":"11746_CR71","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.omtn.2021.02.010","volume":"24","author":"L Zhang","year":"2021","unstructured":"Zhang L, Fang Y, Zhao X, Zheng Y, Ma Y, Li S et al (2021) miR-204 silencing reduces mitochondrial autophagy and ROS production in a murine AD model via the TRPML1-activated STAT3 pathway. Mol Ther Nucleic Acids 24:822\u2013831. https:\/\/doi.org\/10.1016\/j.omtn.2021.02.010","journal-title":"Mol Ther Nucleic Acids"},{"key":"11746_CR72","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.arr.2021.101529","volume":"73","author":"P Gowda","year":"2022","unstructured":"Gowda P, Reddy PH, Kumar S (2022) Deregulated mitochondrial microRNAs in Alzheimer\u2019s disease: Focus on synapse and mitochondria. Ageing Res Rev 73:101529. https:\/\/doi.org\/10.1016\/j.arr.2021.101529","journal-title":"Ageing Res Rev"},{"issue":"8","key":"11746_CR73","doi-asserted-by":"publisher","first-page":"10577","DOI":"10.1007\/s12035-025-04833-5","volume":"62","author":"MJ Saadh","year":"2025","unstructured":"Saadh MJ, Muhammad FA, Alazzawi TS, Fahdil AA, Athab ZH, Tuxtayev J et al (2025) Regulation of Apoptotic Pathways by MicroRNAs: A Therapeutic Strategy for Alzheimer\u2019s Disease. Mol Neurobiol 62(8):10577\u201310613. https:\/\/doi.org\/10.1007\/s12035-025-04833-5","journal-title":"Mol Neurobiol"},{"key":"11746_CR74","doi-asserted-by":"publisher","unstructured":"Kim SH, Choi KY, Park Y, McLean C, Park J, Lee JH et al (2021) Enhanced Expression of microRNA-1273\u00a0g-3p Contributes to Alzheimer\u2019s Disease Pathogenesis by Regulating the Expression of Mitochondrial Genes. Cells 10(10). https:\/\/doi.org\/10.3390\/cells10102697","DOI":"10.3390\/cells10102697"},{"key":"11746_CR75","doi-asserted-by":"publisher","first-page":"113584","DOI":"10.1016\/j.bbr.2021.113584","volume":"417","author":"C Zeng","year":"2022","unstructured":"Zeng C, Meng X, Mai D, Xu K, Qu S (2022) Overexpression of miR-132-3p contributes to neuronal protection in in vitro and in vivo models of Alzheimer\u2019s disease. Behav Brain Res 417:113584. https:\/\/doi.org\/10.1016\/j.bbr.2021.113584","journal-title":"Behav Brain Res"},{"key":"11746_CR76","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fnagi.2015.00061","volume":"7","author":"J Song","year":"2015","unstructured":"Song J, Lee JE (2015) miR-155 is involved in Alzheimer\u2019s disease by regulating T lymphocyte function. Front Aging Neurosci 7:61. https:\/\/doi.org\/10.3389\/fnagi.2015.00061","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"11746_CR77","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1002\/jcp.27214","volume":"234","author":"E Iranifar","year":"2019","unstructured":"Iranifar E, Seresht BM, Momeni F, Fadaei E, Mehr MH, Ebrahimi Z et al (2019) Exosomes and microRNAs: New potential therapeutic candidates in Alzheimer disease therapy. J Cell Physiol 234(3):2296\u20132305. https:\/\/doi.org\/10.1002\/jcp.27214","journal-title":"J Cell Physiol"},{"issue":"11","key":"11746_CR78","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.1002\/alz.13026","volume":"19","author":"J Therriault","year":"2023","unstructured":"Therriault J, Servaes S, Tissot C, Rahmouni N, Ashton NJ, Benedet AL et al (2023) Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer\u2019s disease. Alzheimers Dement 19(11):4967\u20134977. https:\/\/doi.org\/10.1002\/alz.13026","journal-title":"Alzheimers Dement"},{"issue":"8","key":"11746_CR79","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11916-024-01262-2","volume":"28","author":"AE Reis","year":"2024","unstructured":"Reis AE, Spano M, Davis-Hayes C, Salama GR (2024) Lumbar Puncture Complications: A Review of Current Literature. Curr Pain Headache Rep 28(8):803\u2013813. https:\/\/doi.org\/10.1007\/s11916-024-01262-2","journal-title":"Curr Pain Headache Rep"},{"issue":"12","key":"11746_CR80","doi-asserted-by":"publisher","first-page":"e12921","DOI":"10.15252\/emmm.202012921","volume":"12","author":"M Suarez-Calvet","year":"2020","unstructured":"Suarez-Calvet M, Karikari TK, Ashton NJ, Lantero Rodriguez J, Mila-Aloma M, Gispert JD et al (2020) Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer\u2019s continuum when only subtle changes in Abeta pathology are detected. EMBO Mol Med 12(12):e12921. https:\/\/doi.org\/10.15252\/emmm.202012921","journal-title":"EMBO Mol Med"},{"issue":"1","key":"11746_CR81","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12943-022-01509-9","volume":"21","author":"D Yu","year":"2022","unstructured":"Yu D, Li Y, Wang M, Gu J, Xu W, Cai H et al (2022) Exosomes as a new frontier of cancer liquid biopsy. Mol Cancer 21(1):56. https:\/\/doi.org\/10.1186\/s12943-022-01509-9","journal-title":"Mol Cancer"},{"key":"11746_CR82","doi-asserted-by":"publisher","unstructured":"Varesi A, Carrara A, Pires VG, Floris V, Pierella E, Savioli G et al (2022) Blood-based biomarkers for Alzheimer\u2019s disease diagnosis and progression: an overview. Cells 11(8). https:\/\/doi.org\/10.3390\/cells11081367","DOI":"10.3390\/cells11081367"},{"key":"11746_CR83","doi-asserted-by":"publisher","first-page":"120542","DOI":"10.1016\/j.cca.2025.120542","volume":"578","author":"S Liu","year":"2026","unstructured":"Liu S, Zhao M, Yang X, Liu Y, Xu H, Yan H et al (2026) Exosomal microRNA biomarkers in Alzheimer\u2019s disease: Systematic review and meta-analysis. Clin Chim Acta 578:120542. https:\/\/doi.org\/10.1016\/j.cca.2025.120542","journal-title":"Clin Chim Acta"},{"issue":"3","key":"11746_CR84","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton NJ, Brum WS, Di Molfetta G, Benedet AL, Arslan B, Jonaitis E et al (2024) Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology. JAMA Neurol 81(3):255\u2013263. https:\/\/doi.org\/10.1001\/jamaneurol.2023.5319","journal-title":"JAMA Neurol"},{"issue":"7","key":"11746_CR85","doi-asserted-by":"publisher","first-page":"R78","DOI":"10.1186\/gb-2013-14-7-r78","volume":"14","author":"P Leidinger","year":"2013","unstructured":"Leidinger P, Backes C, Deutscher S, Schmitt K, Mueller SC, Frese K et al (2013) A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol 14(7):R78. https:\/\/doi.org\/10.1186\/gb-2013-14-7-r78","journal-title":"Genome Biol"},{"key":"11746_CR86","doi-asserted-by":"publisher","first-page":"1591796","DOI":"10.3389\/fnagi.2025.1591796","volume":"17","author":"M Cardillo","year":"2025","unstructured":"Cardillo M, Katam K, Suravajhala P (2025) Advancements in multi-omics research to address challenges in Alzheimer\u2019s disease: a systems biology approach utilizing molecular biomarkers and innovative strategies. Front Aging Neurosci 17:1591796. https:\/\/doi.org\/10.3389\/fnagi.2025.1591796","journal-title":"Front Aging Neurosci"},{"key":"11746_CR87","doi-asserted-by":"publisher","unstructured":"Abir AR, Dip SA, Zhang L (2025) UnCOT-AD: unpaired cross-omics translation enables multi-omics integration for Alzheimer\u2019s disease prediction. Brief Bioinform 26(4). https:\/\/doi.org\/10.1093\/bib\/bbaf438","DOI":"10.1093\/bib\/bbaf438"},{"issue":"2","key":"11746_CR88","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3233\/JAD-230966","volume":"98","author":"S Kavoosi","year":"2024","unstructured":"Kavoosi S, Shahraki A, Sheervalilou R (2024) Identification of microRNA-mRNA Regulatory Networks with Therapeutic Values in Alzheimer\u2019s Disease by Bioinformatics Analysis. J Alzheimers Dis 98(2):671\u2013689. https:\/\/doi.org\/10.3233\/JAD-230966","journal-title":"J Alzheimers Dis"},{"key":"11746_CR89","doi-asserted-by":"publisher","unstructured":"Titze-de-Almeida SS, Marina CL, Ramos MV, Silva L, Brandao PRP, Bispo DDC et al (2025) Exosomal non-coding RNAs as potential biomarkers for Alzheimer\u2019s disease: advances and perspectives in translational research. Int J Mol Sci 26(17). https:\/\/doi.org\/10.3390\/ijms26178246","DOI":"10.3390\/ijms26178246"},{"issue":"327","key":"11746_CR90","doi-asserted-by":"publisher","first-page":"pe14","DOI":"10.1126\/scisignal.2005407","volume":"7","author":"CW Winkler","year":"2014","unstructured":"Winkler CW, Taylor KG, Peterson KE (2014) Location is everything: let-7b microRNA and TLR7 signaling results in a painful TRP. Sci Signal 7(327):pe14. https:\/\/doi.org\/10.1126\/scisignal.2005407","journal-title":"Sci Signal"},{"issue":"1","key":"11746_CR91","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman RC, Farh KK, Burge CB, Bartel DP (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19(1):92\u2013105. https:\/\/doi.org\/10.1101\/gr.082701.108","journal-title":"Genome Res"},{"issue":"2","key":"11746_CR92","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12031-018-1135-x","volume":"66","author":"M Izadpanah","year":"2018","unstructured":"Izadpanah M, Seddigh A, Ebrahimi Barough S, Fazeli SAS, Ai J (2018) Potential of extracellular vesicles in neurodegenerative diseases: diagnostic and therapeutic indications. J Mol Neurosci 66(2):172\u2013179. https:\/\/doi.org\/10.1007\/s12031-018-1135-x","journal-title":"J Mol Neurosci"},{"key":"11746_CR93","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3389\/fnins.2019.01208","volume":"13","author":"DJ Cha","year":"2019","unstructured":"Cha DJ, Mengel D, Mustapic M, Liu W, Selkoe DJ, Kapogiannis D et al (2019) miR-212 and miR-132 are downregulated in neurally derived plasma exosomes of Alzheimer\u2019s patients. Front Neurosci 13:1208. https:\/\/doi.org\/10.3389\/fnins.2019.01208","journal-title":"Front Neurosci"},{"key":"11746_CR94","doi-asserted-by":"publisher","first-page":"581545","DOI":"10.3389\/fcell.2020.581545","volume":"8","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wang W, Wang Y, Zhao H, Han X, Zhao T et al (2020) Extracellular vesicle-encapsulated miR-29b-3p released from bone marrow-derived mesenchymal stem cells underpins osteogenic differentiation. Front Cell Dev Biol 8:581545. https:\/\/doi.org\/10.3389\/fcell.2020.581545","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"11746_CR95","doi-asserted-by":"publisher","first-page":"13356","DOI":"10.1038\/s41598-017-13470-5","volume":"7","author":"J Shu","year":"2017","unstructured":"Shu J, Silva B, Gao T, Xu Z, Cui J (2017) Dynamic and modularized MicroRNA regulation and its implication in human cancers. Sci Rep 7(1):13356. https:\/\/doi.org\/10.1038\/s41598-017-13470-5","journal-title":"Sci Rep"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11746-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11746-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11746-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:45:51Z","timestamp":1774943151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11746-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11746"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11746-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"558"}}